Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 141.54% | 30.53% | -16.05% | -92.59% | -53.97% |
Total Depreciation and Amortization | 20.13% | 12.43% | 5.75% | 6.71% | 3.96% |
Total Amortization of Deferred Charges | 28.23% | 18.98% | 12.55% | 13.47% | 43.24% |
Total Other Non-Cash Items | -120.69% | -61.60% | 28.38% | 215.07% | 365.28% |
Change in Net Operating Assets | -28.80% | -124.12% | 369.98% | 180.50% | 126.98% |
Cash from Operations | 9.92% | -25.21% | 108.96% | 558.11% | 1,583.06% |
Capital Expenditure | 2.14% | -7.99% | -20.09% | 20.38% | 26.02% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -8,793.30% | -8,642.66% | -- | -- | -20.44% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 659.86% | 224.93% | 129.24% | 83.47% | 60.43% |
Cash from Investing | -489.01% | -207.44% | 51.15% | 34.89% | 32.63% |
Total Debt Issued | 409.79% | 471.70% | 157.92% | -15.18% | -23.73% |
Total Debt Repaid | -321.39% | -348.10% | -178.82% | 6.29% | 7.35% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.02% | 0.01% | 0.00% | 0.00% | 0.00% |
Other Financing Activities | -345.65% | -211.95% | -321.59% | -80.52% | -445.63% |
Cash from Financing | 1,555.55% | 1,404.23% | -3,496.62% | -125.08% | -132.57% |
Foreign Exchange rate Adjustments | -42.05% | -92.77% | -349.19% | -537.67% | -268.03% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -22.01% | 196.20% | 126.21% | 188.97% | 138.76% |